Paul T Spellman

Title: Paul T Spellman: Innovator in Cancer Therapeutics

Introduction

Paul T Spellman is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of cancer research, particularly in understanding therapeutic responses to anti-cancer agents. His work has implications for improving treatment strategies for breast cancer patients.

Latest Patents

Paul T Spellman holds a patent titled "Molecular predictors of therapeutic response to specific anti-cancer agents." This patent describes the use of a collection of 50 breast cancer cell lines to match responses to 77 conventional and experimental therapeutic agents with transcriptional, proteomic, and genomic subtypes found in primary tumors. Almost all compounds produced strong differential responses across the cell lines, which were associated with transcriptional and proteomic subtypes. Additionally, these responses were linked to recurrent genome copy number abnormalities. The associations identified can now be incorporated into clinical trials that test subtype markers and clinical responses simultaneously. He has 1 patent to his name.

Career Highlights

Throughout his career, Paul has worked with prestigious institutions such as the University of California and Oregon Health & Science University. His research has focused on enhancing the understanding of cancer treatment and improving patient outcomes through innovative approaches.

Collaborations

Paul T Spellman has collaborated with notable colleagues, including Joe W Gray and Anguraj Sadanandam. These collaborations have contributed to advancing research in cancer therapeutics and have fostered a collaborative environment for scientific discovery.

Conclusion

Paul T Spellman is a distinguished inventor whose work in cancer therapeutics has the potential to transform treatment methodologies. His innovative research continues to pave the way for advancements in personalized medicine for cancer patients.